Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
The study suggests that increasing T cells’ exposure to potassium may make cancer immunotherapies more effective.
Three independent studies suggest a way to thwart a mutated gene that drives tumor growth in 95 percent of people with the disease.
The study found that removing nearby lymph nodes didn’t improved survival rates and was associated with serious post-surgical complications.
It’s estimated that more than half of all cancer drugs and antibiotics originated from a chemical compound discovered in a natural product.
In two large clinical trials, an immune checkpoint inhibitor combined with a targeted therapy had better outcomes than the standard of care.
NCI is expanding eligibility criteria for its cancer clinical trials in the hope that more people will enroll.
Multipronged approach eliminated treatment gaps between black and white patients and improved overall treatment rates.
National Institutes of Health scientists use epigenetics to help predict disease development.
Scientists seek to design clinical trials to test therapies that are tailored to the specific genetic drivers of rare tumors.
Overall, the therapy worked very well in the mice used in the study. The first human clinical trial will be in adult brain cancers.
The Human Tumor Atlas Network initiative will create maps of human tumors and their surrounding environment.
The cost of treating complications of invasive diagnostic procedures can be substantial.
Experts say the regimen will become the standard of care for people up to age 40 who are newly diagnosed with acute lymphoblastic leukemia.
“More of these studies are needed to make progress in…precision, or personalized, medicine,” said NCI’s Konstantin Salnikow, PhD.
But, despite the difference, the risk of dying from the disease is still small.
Researchers are learning new ways to manage common types of cancer pain, like bone pain and neuropathy pain.
Worldwide, more than 21 million new cases of cancer are predicted to occur in 2030.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.